Can you tell a Perfect Enemy? | Page 1060 | theperfectenemy.com
July 9, 2025

Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial

Bavarian Nordic A/SCOPENHAGEN, Denmark, October 17, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the results of a six-month...